By Rob Stein - NPR News Katie Pope Kopp went through round after round of chemotherapy and a stem cell transplant to treat her non-Hodgkin lymphoma. But nothing could beat it. "I went back to get a PET scan in May of 2020, and that's when they found that my...

By Anjali A. Sarkar, PhD - Genetic Engineering & Biotechnology news Researchers are developing off-the-shelf treatments to save joints before they wear out Osteoarthritis is a progressive disease where the protective layer of articular cartilage that cushions the...

by Lynda Charters - Ophthalmology Times A recent survey of retinal clinic patients reveals a lack of awareness of the risks and safety issues associated with stem cell therapies. Intravitreal injections of unapproved stem cell therapies have resulted in irreversible...

by Tokyo Medical and Dental University - Phys.Org Growing miniature organ-like tissues in the lab is already within our reach. Now, researchers from Japan have developed a new approach that enables intestinal mini-organs to be grown more easily and efficiently in the...

By: Stacey DeLoye - UFHealth News Scientists at UF Scripps Biomedical Research have developed a potential medicine for a leading cause of ALS and dementia that works by eliminating disease-causing segments of RNA. The compound restored the health of neurons in the lab...

By Technology Netowrks Northwestern University-led researchers have created the first highly mature neurons from human induced pluripotent stem cells (iPSCs), a feat that opens new opportunities for medical research and potential transplantation therapies for...

By Andrea Park, Conor Hale - Fierce Biotech SAN FRANCISCO—After years of stops, starts and stops again, the J.P. Morgan Healthcare Conference has returned to the city by the bay in full form. Below we've compiled the biggest medtech news so far, bite-sized—from both...

Manipulating Cell Signaling Can Possibly Ensure the Body Has a Healthy Amount of Cells By Stephanie Cajigal - Cedars Sinai A new study led by Cedars-Sinai and the University of California, San Francisco (UCSF), has determined that altering a cellular process can lead...

By Allison Gatlin - Investors.com If there's one overarching theme that investors in biotech stocks should pay attention to in 2023, it's "genetic medicine, genetic medicine, genetic medicine," says Christopher Anzalone. Anzalone is biased, of course. He's the chief...

Michael Druckman, Meredith Manning, and  Ashley Grey – Hogan Lovells Last year, a federal court in California ruled against the U.S. Food and Drug Administration (FDA) in a matter where the government alleged that a stem cell clinic’s products should be regulated as...

by William A. Haseltine  - Forbes Here we describe early clinical trial results on combination CRISPR and CAR T therapy, a sequel to an earlier, introductory piece. Other alternative CAR T designs include mRNA vectors to create temporary CAR T cells and the use of...

by Tokyo Medical and Dental University - Phys.org Growing miniature organ-like tissues in the lab is already within our reach. Now, researchers from Japan have developed a new approach that enables intestinal mini-organs to be grown more easily and efficiently in the...